IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.
August 08, 2024 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...
Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST)
August 08, 2024 07:30 ET
|
Kura Oncology, Inc.
– Preclinical data suggest combination of ziftomenib and imatinib has potential to resensitize patients to imatinib and induce durable responses – – Proof-of-concept study evaluating ziftomenib...
Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024 07:00 ET
|
Cartesian Therapeutics, Inc.
Presented positive topline results from Phase 2b trial of Descartes-08 in patients with myasthenia gravis; End-of-Phase 2 meeting with FDA expected by year-end Dosed first SLE patient in Phase 2...
Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
August 08, 2024 07:00 ET
|
Eyenovia, Inc.
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today...
Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024
August 08, 2024 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON , Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
August 08, 2024 07:00 ET
|
EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives...
BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease
August 08, 2024 06:00 ET
|
BioVie, Inc.
SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson’s disease who are naïve to carbidopa/levodopa Company engaged in trial start-up...
Dr. Brian Buinewicz is a Featured Speaker at the 2024 Breast Implant Illness Summit
August 08, 2024 00:42 ET
|
Buinewicz Plastic Surgery
DOYLESTOWN, Pa., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Board-certified plastic surgeon Dr. Brian Buinewicz, known for offering a wide a range of cosmetic and functional procedures at Buinewicz Plastic...
Greg Horn Honored with NBJ Lifetime Achievement Award For Transformative Impact on Health and Wellness
August 07, 2024 16:28 ET
|
Specialty Nutrition Consulting
Nutrition Business Journal honored Greg Horn with the prestigious NBJ Lifetime Achievement Award at the NBJ Summit for his transformative impact on health.
Breakthrough Study Reveals Molecular Subtypes of Down Syndrome, Offering Insights for Personalized Medicine Approaches
August 07, 2024 16:27 ET
|
Global Down Syndrome Foundation
Denver, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Global Down Syndrome Foundation (GLOBAL) is proud to support a new study published in Nature Communications by researchers at its partner and Affiliate,...